Natus Medical

Natus Medical financials

Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

Natus Medical financials data including stock price, CreditSafe score, income statement, balance sheet, cash flow, and acquistions and subsidiaries.

Stock Price

$33

2022-07-21

Market Capitalization

$1.1 B

2022-07-21

Revenue

$473.4 M

FY, 2021

CreditSafe score

Score changed on Mar 30, 2023

Premium Content

USD	FY, 2019	FY, 2020	FY, 2021
Revenue	495.2M	415.7M	473.4M
Revenue growth, %	-6.7%	-16.1%
Cost of goods sold	196.6M	185.9M	193.0M
Gross profit	291.7M	216.5M	273.7M
Gross profit margin, %	58.9%	52.1%	57.8%
General and administrative expense	59.6M	49.1M	52.8M
Operating expense total	307.4M	236.7M	249.9M
Depreciation and amortization	15.1M	15.2M	17.1M
EBIT	(15.7M)	(20.2M)	23.8M
EBIT margin, %	-3.2%	-4.9%	5.0%
Interest income	250.0K	11.0K
Interest expense	4.9M	3.7M
Pre tax profit	(21.3M)	(22.1M)	19.4M
Income tax expense	(5.6M)	(5.5M)	6.2M
Net Income	(15.7M)	(16.6M)	13.2M
EPS	(0.5)	(0.5)	0.4

Company name	Date	Deal size
Lorem	Dec 23, 2021	$40.0M
Ipsum	Jan 18, 2022	$30.0M
Lorem Ipsum	Feb 18, 2022	$25.0M
Dolor	Oct 21, 2021	$60.0M
Premium Content View acquisitions and subsidiaries by company, date, and deal size. Understanding this data enables better supplier & customer negotiations and helps identify potential opportunities or market risks for your firm. Learn more